InvestorsHub Logo
Followers 516
Posts 38725
Boards Moderated 5
Alias Born 04/26/2012

Re: None

Saturday, 01/12/2019 7:48:27 PM

Saturday, January 12, 2019 7:48:27 PM

Post# of 955
LEXINGTON, Mass., Sept. 24, 2018 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer, today announced a change in leadership with the appointment of James E. Dentzer as President and Chief Executive Officer effective immediately. In addition, Mr. Dentzer will become a member of the Curis Board of Directors. He replaces Ali Fattaey, Ph.D., who is leaving the Company.



:)

All my posts are my opinion only. Please do your due diligence on all your investments.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRIS News